[ Price : $8.95]
FDA accepts for priority review a Gamida Cell BLA for omidubicel for treating patients with blood cancers in need of an allogenic ...[ Price : $8.95]
FDA publishes 48 new and revised product-specific guidances in its latest batch.[ Price : $8.95]
Federal Register notice: FDA withdraws the approval of seven ANDAs from multiple applicants after they notified the agency that th...[ Price : $8.95]
North American Diagnostics recalls its Oral Rapid SARS-CoV-2 Rapid Antigen Test Kits because they were distributed without FDA aut...[ Price : $8.95]
FDA issues a clinical hold on Beam Therapeutics BEAM-201 and its use in treating relapsed/refractory T-cell acute lymphoblastic le...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection entitled Reporting Associated With Designated New Animal ...[ Price : $8.95]
FDA accepts for review an ImmunityBio BLA for its antibody cytokine fusion protein as a treatment for certain patients with Bacill...[ Price : $8.95]
FDA removes a clinical hold on Celyad Oncologys CYAD-101-002 (KEYNOTE-B79) Phase 1b trial after the company modified the eligibili...